Decentralized tech reduces COVID-era patient burdens: Rho
A leader from the CRO discusses how the COVID-19 pandemic has accelerated decentralized adoption, and how such trials lead to benefits for participants.
A leader from the CRO discusses how the COVID-19 pandemic has accelerated decentralized adoption, and how such trials lead to benefits for participants.
According to one New Yorker, encountering the AI-assisted TrialJectory technology helped cut through the uncertainty to provide information and solutions.
The precision medicine firm is joining with the oncology network in an effort to help improve treatment options and outcomes for cancer patients worldwide.
A leader from the CRO discusses the vital role participants play in a clinical study’s success, and what it truly means to be patient centric.
An expert from the global pharmaceutical firm shares how working with other organizations and putting patients at the center can benefit clinical research.
A leader from the trial patient services specialist discusses the importance of keeping the participant’s vital role top of mind in research studies.
The federal agency has offered updates, advice and action regarding the COVID-19 pandemic, helping life-sciences professionals stay on top of developments.